Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.055 USD | -0.47% | +4.50% | -24.28% |
05-09 | Transcript : Bluebird bio, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
05-06 | Bluebird Bio, Inc. Announces Completion of First Cell Collection for LYFGENIA Gene Therapy | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.09% | 204M | |
+4.97% | 109B | |
+11.27% | 105B | |
-0.38% | 22.25B | |
-12.21% | 22.09B | |
-7.66% | 18.68B | |
-36.52% | 17.58B | |
-9.85% | 16.85B | |
+4.51% | 13.76B | |
+34.99% | 12.46B |
- Stock Market
- Equities
- BLUE Stock
- News bluebird bio, Inc.
- Bluebird bio Launches $150 Million Share Offering